전체 프로그램

ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-5 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved2,403 programs
AntibodyLimited DatastaleMacroGenicsPhase 1

lorigerlimab (lorigerlimab)

Advanced Solid Tumor; Castration-Resistant Prostatic Cancer · Advanced Solid Tumor

#AdvancedSolidTumor#Antibody#Phase1#monoclonal-antibody#Castration-ResistantProstaticCan+1
Trials 9Status Active
CGTLimited DatastaleStephan Grupp MD PhDPhase 1

CART123 (Anti-CD123 LV redirected T cells, Anti-CD123 LV redirected T cells (CART123))

Acute Myeloid Leukemia (AML) · Acute Myeloid Leukemia (AML)

#AcuteMyeloidLeukemiaAML#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 8Status Recruiting
ADCLimited DatastalePfizerPreclinical

Antibody Drug Conjugate Chemotherapeutic (Antibody Drug Conjugate Chemotherapeutic)

CD33 Positive Acute Myelogenous Leukemia · CD33

#CD33#ADC#Preclinical#antibody-drug-conjugate#CD33PositiveAcuteMyelogenousLeuk+1
Trials 8Status Active
CGTLimited DatastaleHebei Senlang Biotechnology Inc…Phase 1

Autologous CD19/CD22/CD20 Chimeric Antigen Receptor T-cells (Autologous CD19/CD22/CD20 Chimeric Antigen Receptor T-cells)

19 and 22+ B Cell Hematologic Tumors; 19 and 20+ B Cell Hematologic Tumors · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 8Status Recruiting
AntibodyLimited DatastaleJin-hong ChenPhase 2

Cadonilimab+regorafenib (Cadonilimab+regorafenib)

Advanced Hepatocellular Carcinoma · Advanced Hepatocellular Carcinoma

#AdvancedHepatocellularCarcinoma#Antibody#Phase2#monoclonal-antibody#Jin-hong
Trials 8Status Active
ADCLimited DatastaleAbbViePhase 3

Depatuxizumab mafodotin (Depatuxizumab mafodotin)

Glioblastoma · Glioblastoma

#Glioblastoma#ADC#Phase3#antibody-drug-conjugate#AbbVie
Trials 8Status Active
AntibodyLimited DatastaleMacroGenicsPhase 2

Flotetuzumab (Flotetuzumab)

Relapsed Acute Myeloid Leukemia · Relapsed Acute Myeloid Leukemia

#RelapsedAcuteMyeloidLeukemia#Antibody#Phase2#monoclonal-antibody#MacroGenics
Trials 8Status Discontinued
CGTStandard DatabasestaleThe First Hospital of Jilin Uni…Phase 2

IL-15-armored CAR-T cells (IL-15-armored CAR-T cells)

Relapsed/Refractory Multiple Myeloma; Plasma Cell Leukemia (PCL) · FRα

#FR#CGT#Phase2#cell-gene-therapy#CAR-T+5
Trials 8Status Recruiting
CGTLimited DatastaleTILT Biotherapeutics Ltd.Phase 1

Oncolytic virus Plus Anti-PD1 and Chemotherapy (Oncolytic virus Plus Anti-PD1 and Chemotherapy)

Pancreatic Cancer · Pancreatic Cancer

#PancreaticCancer#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 8Status Recruiting
CGTLimited DatastaleShanghai Yunying Medical Techno…Phase 1

R130 (Recombinant oncolytic herpes simplex virus type Ⅰ, Recombinant oncolytic herpes simplex virus type Ⅰ (R130))

Osteosarcoma; Sarcoma · Osteosarcoma

#Osteosarcoma#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 8Status Active
AntibodyLimited DatastaleInnoventPhase 2

Sintilimab+Pegaspargase (Sintilimab+Pegaspargase)

Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type · Natural Killer/T-Cell Lymphoma, Nasal an

#NaturalKillerT-CellLymphomaNasal#Antibody#Phase2#monoclonal-antibody#NaturalKiller+3
Trials 8Status Recruiting
CGTLimited DatastaleNational Heart, Lung, and Blood…Phase 2

ATLCAR.CD30 T cells (ATLCAR.CD30 T cells)

Peripheral T Cell Lymphoma · CD30

#CD30#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 7Status Recruiting
AntibodyLimited DatastaleRochePhase 3

atezolizumab (Tecentriq, Atezolizumab and Recombinant Human Hyaluronidase)

Lung Non-Small Cell Carcinoma; Stage II Lung Cancer AJCC v8 · Lung Non-Small Cell Carcinoma

#LungNon-SmallCellCarcinoma#Antibody#Phase3#monoclonal-antibody#StageIILungCancerAJCCv8+1
Trials 7Status Recruiting
CGTLimited DatastaleMiltenyi Biotec, Inc.Phase 1

Autologous CAR19 T lymphocytes (Autologous CAR19 T lymphocytes)

Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia; Non-Hodgkin's Lymphoma Refractory · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 7Status Recruiting
CGTLimited DatastaleHangzhou Qihan Biotech Co., Ltd.Phase 1

CD33 CAR-NK cell (CD33 CAR-NK cell)

AML, Adult; Minimal Residual Disease · CD33

#CD33#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 7Status Active
CGTLimited DatastaleCartesian TherapeuticsPhase 2

Descartes-08 (Descartes-08)

Antisynthetase Syndrome · Antisynthetase Syndrome

#AntisynthetaseSyndrome#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 7Status Recruiting
AntibodyLimited DatastaleHoffmann-La RochePhase 3

Emactuzumab (Emactuzumab)

Cancer · Cancer

#Cancer#Antibody#Phase3#monoclonal-antibody#Hoffmann-La
Trials 7Status Recruiting
CGTLimited DatastaleSichuan UniversityPhase 1

EpCAM CAR-T cells (EpCAM CAR-T cells)

Malignant Neoplasm of Nasopharynx TNM Staging Distant Metastasis (M); Breast Cancer Recurrent · Malignant Neoplasm of Nasopharynx TNM St

#MalignantNeoplasmofNasopharynxTN#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 7Status Active
AntibodyLimited DatastaleImmunoGen, Inc.Phase 2

Lorvotuzumab Mertansine (Lorvotuzumab Mertansine)

Pleuropulmonary Blastoma; Recurrent Malignant Peripheral Nerve Sheath Tumor · Pleuropulmonary Blastoma

#PleuropulmonaryBlastoma#Antibody#Phase2#monoclonal-antibody#RecurrentMalignantPeripheralNerv+1
Trials 7Status Active
CGTLimited DatastaleMiltenyi Biomedicine GmbHPhase 2

MB-CART19.1 (MB-CART19.1)

Precursor B-Lymphoblastic Lymphoma/Leukaemia Refractory · Melanoma Stage III

#MelanomaStageIII#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 7Status Active

26 / 121 pages

← PreviousNext →